$1 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$14.4 MillionTotal revenue in the last quarter.
$-400 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
-Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$-7.68 MillionEarnings before interest expenses and taxes in the last quarter.
-The number of full time employees.
Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.
BidaskClub upgraded shares of Genetron (NASDAQ:GTH) from a strong sell rating to a sell rating in a report issued on Thursday, BidAskClub reports. GTH opened at $11.36 on Thursday. Genetron has a 5...Dakota Financial News, 3 days ago
Genetron (NASDAQ:GTH) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Thursday, BidAskClub reports. Shares of NASDAQ:GTH op...Dispatch Tribunal, 5 days ago
Celcuity (NASDAQ:CELC) and Genetron (NASDAQ:GTH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earni...The Lincolnian, 7 days ago